GH.NASDAQGuardant Health, INC
Form 4: Guardant Health Executive Chris Freeman Reports Stock Transactions
Sentiment:
SEC Filing
Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting of restricted stock units and associated tax withholding.
Summary
- Chris Freeman, Chief Commercial Officer of Guardant Health, filed a Form 4 detailing changes in beneficial ownership.
- On September 15, 2024, Freeman vested 1,402 shares of common stock from restricted stock units.
- 597 shares were withheld by the company to cover tax obligations related to the vesting.
- Following these transactions, Freeman directly owns 26,574 shares of Guardant Health common stock and 9,813 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which carries a neutral sentiment.
Key Dates
| Date | Description |
|---|---|
| June 9, 2023 | Date of restricted stock unit award grant. |
| June 15, 2024 | First vesting date of the restricted stock unit award (33%). |
| September 15, 2024 | Date of stock vesting and tax withholding. |
| September 16, 2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.